Glenmede Trust’s Zomedica Corp. ZOM Stock Holding History

Glenmede Trust’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-243,000	Closed	-$29.2K	–	1457
2024 Q4	$29.2K	Hold	243,000	–	–	﹤0.01%	1348
2024 Q3	$33.3K	Hold	243,000	–	–	﹤0.01%	1331
2024 Q2	$35.5K	Hold	243,000	–	–	﹤0.01%	1295
2024 Q1	$35.5K	Hold	243,000	–	–	﹤0.01%	1281
2023 Q4	$48.6K	Hold	243,000	–	–	﹤0.01%	1227
2023 Q3	$40.6K	Hold	243,000	–	–	﹤0.01%	1184
2023 Q2	$51.4K	Hold	243,000	–	–	﹤0.01%	1197
2023 Q1	$51.4K	Hold	243,000	–	–	﹤0.01%	1203
2022 Q4	$39.6K	Hold	243,000	–	–	﹤0.01%	1202
2022 Q3	$51K	Hold	243,000	–	–	﹤0.01%	1180
2022 Q2	$53K	Buy	243,000 +63,000	+35%	+$16K	﹤0.01%	1190
2022 Q1	$60K	Hold	180,000	–	–	﹤0.01%	1224
2021 Q4	$55K	Buy	180,000 +60,000	+50%	+$27K	﹤0.01%	1233
2021 Q3	$62K	Buy	+120,000	New	+$70.8K	﹤0.01%	1200

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

JWM

Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Glenmede Trust's ZOM Position: Q1 2025 in Review

Glenmede Trust sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 243,000 shares — an estimated $29.2K sold.

Glenmede Trust first reported a position in ZOM in Q3 2021 and held it in 14 quarters. The position peaked at $62K in Q3 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

Glenmede Trust reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
Glenmede Trust sold 243,000 Zomedica Corp. shares in Q1 2025, an estimated $29.2K.
Glenmede Trust first reported a position in Zomedica Corp. in Q3 2021 and held it in 14 quarters.
Glenmede Trust's Zomedica Corp. position peaked at $62K in Q3 2021.
23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.